Stoke Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Stoke Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $-0.47 | $-0.53 | 11.3 % |
Jun 2024 | 2024-08-07 | $-0.46 | $-0.55 | 16.4 % |
Mar 2024 | 2024-05-06 | $-0.57 | $-0.61 | 6.56 % |
Dec 2023 | 2024-03-25 | $-0.60 | $-0.63 | 4.76 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $4.89M | $3.35M | 46.1 % |
Jun 2024 | 2024-08-07 | $4.83M | $3.41M | 41.7 % |
Mar 2024 | 2024-05-06 | $4.22M | $3.21M | 31.3 % |
Dec 2023 | 2024-03-25 | $2.80M | $3.25M | -13.8 % |
Stoke Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3.
Stoke Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was $-0.47, which beat the estimate of $-0.53.
Stoke Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.